Leading contract provider of integrated discovery, development and manufacturing services for biologics and bioconjugates, Abzena, has invested $60 million into a new facility for late phase and commercial cGMP manufacturing.   The new ~50,000 square foot ‘Lusk’ facility, at the company’s site in San Diego, CA, houses a process development laboratory and two new cGMP manufacturing cleanrooms for 500L and 2,000L scale in Sartorius single use bioreactors. The facility also houses a GMP warehouse, ...